Saturday, June 1, 2019

Allergan wins less than $50000 in case against compounder Imprimis

Reuters-May 17, 2019
... compounded drugs that bypass regulatory approval, including a cheaper alternative to Allergan's dry eye drug Restasis, according to a lawyer for Imprimis

No comments: